FDA Approves First Postpartum Depression Pill in US: What to Know

Labeling of the drug says it could spark suicidal thoughts and cause fetal harm

A father and a mother look at their newborn son at the maternity of the Diaconesses hospital in Paris, on Nov. 17, 2020. Martin Bureau/AFP via Getty Images

The U.S. Food and Drug Administration has for the first time approved a pill to treat postpartum depression, a condition that affect millions of mothers.

Until now, treatment for postpartum depression in the United States was available only as an IV injection that could be given by a health care provider in certain health care facilities.